Soluble guanylate cyclase: a potential therapeutic target for heart failure. - Wikidata - wikimedia - TriplyDB

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

http://www.wikidata.org/entity/Q38012596

about

Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes Potential new drug treatments for congestive heart failure.Silent disease progression in clinically stable heart failure.Cyclic nucleotide signalling in kidney fibrosis.Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.Effect of asymmetric dimethylarginine (ADMA) on heart failure development.The NO/ONOO-cycle as the central cause of heart failure.Riociguat: first global approval.Vasodilators in Acute Heart Failure: Review of the Latest Studies.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).The Three-Decade Long Journey in Heart Failure Drug Development.New medical therapies for heart failure.From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials.Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure.New pharmacological approaches in heart failure therapy: developments and possibilities.Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection.Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.

P2860

Q26853363-2CC43063-9BEA-4863-96DD-65F4C29AEC30 Q27021649-91374CF8-4CDE-4210-B2B2-25F078530E00 Q27024279-CDB908ED-80B5-444A-A79C-1615F5E52CA6 Q27677544-FF4A800A-299F-4CA5-85E2-4E7AC4BD2126 Q30251531-72FBF2A3-0A47-4D4C-8A80-D8BC033EA3C0 Q33578212-A417C18A-AA71-4663-A11A-2AEB8D54A4AC Q35138860-3714281A-709F-4ECF-98C5-DBBD85A3B2C4 Q36868978-898012B3-64F4-4D78-BE51-14155CFC69D1 Q37245523-D53FBCEA-B160-482D-98A6-66FF15B9649C Q37375441-FAD9A930-7FA0-4739-8F47-9E7479EC2A95 Q38161841-4D0B7A93-DD50-4394-B361-E752409CF3FB Q38214097-4F81F52F-84B9-4078-92CE-CB5CB0635F87 Q38546917-2A35C6BA-DE5E-444B-8FD8-42C7739BEB39 Q38558614-78659A73-14CC-49C6-B4E0-1862A261AB0E Q38594785-26E2D943-32A7-4655-8BFE-8173BCEF3737 Q38612665-AC168AB0-E200-4BCD-A53E-0488171DE78B Q38670275-C9238A34-06CB-4ADD-B798-4162F1357DB8 Q38737757-45CC28B2-4D06-41E8-A3D8-207DEDEC299F Q38759494-703730ED-A646-4544-88CB-0D974E81D0E9 Q38818606-6C7C8B72-6146-4216-B21C-8B295F212A6B Q39024203-F62FB2BD-ADB1-4769-84B9-118131C320C9 Q39080324-6F860968-78C8-475A-8CFA-D95777B3B869 Q48640874-53D27CF0-B16C-45D6-B0F9-CD09E4E90884 Q49718583-7970482B-739D-422D-A65C-6AB3532956DD Q52670776-46B8E9A0-44AD-417A-8E74-C96C0A9C7EF7

P2860

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

http://www.wikidata.org/entity/Q38012596

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

@en

type

label

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

@en

prefLabel

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

@en

P1433

Q38012596-583BD419-0FB6-475C-B866-EC5047CFA0C2

P1476

Q38012596-41C0AB6D-5558-45D1-8619-A467B0021FF9

P2093

Q38012596-0B4A9E10-CC9C-439E-8A6E-BD903EECD960

Q38012596-649831EF-9716-424E-BEF4-8086B5F3C6FF

Q38012596-6D92A5D4-02E2-4A21-BF7C-FC75F24F8C9B

Q38012596-774B4083-39A4-4CDE-BD23-0E6926CF22BE

Q38012596-8528A0D1-6C3D-4ED5-AD4D-BB6E588EB434

Q38012596-86A73FC5-825B-4572-A489-6438B92E7E52

Q38012596-8DC7B275-1C80-4A51-A7E4-980396902F4C

Q38012596-A58D906A-2C3F-46D0-AEFD-92B3DFF07039

Q38012596-EBF3CC35-D643-4F1B-BF50-24C97CAD8981

Q38012596-EF6708A6-12C6-4AB2-8C17-101CFDD2D1FA

P2860

Q38012596-03FDA0B7-090F-4479-8116-3520B3998231

Q38012596-0D151725-6FFB-4F58-AC36-03DA9891D15D

Q38012596-0E9BADD8-CEF9-4E30-9617-EA3012B8CFCD

Q38012596-1591B5E4-D083-410F-B75E-2E7E131A2C4C

Q38012596-184B5229-5411-478D-B723-27F012CB71D2

Q38012596-18A173CA-A9CE-46DE-8C0C-B0764116545C

Q38012596-1A14B416-DFEE-4076-9379-03354A485735

Q38012596-1C438F74-7577-4D82-87D7-DE8E3D3E7060

Q38012596-23924079-C3B9-4A42-9967-78AC5443B840

Q38012596-24DC45D3-D2A9-471B-AD42-8EA3A3F1CDC1

P2888

Q38012596-9AAC57E3-C1C0-41FC-88E0-42937C7EDA33

P304

Q38012596-A504B84E-AD26-4AF6-9686-B4C161D6DF15

P31

Q38012596-1541B7E2-5C9A-4BEB-9AFC-169177DF3464

P356

Q38012596-AAA397E3-FE05-434A-93E3-B8E608F9A240

P433

Q38012596-5D02335E-A9C2-4CF7-ADEE-0D2936695B70

P478

Q38012596-58F29726-3313-41BB-9D18-EC5547D93B37

P50

Q38012596-13F198C1-B0BE-4813-ABC5-79BD77DC6230

Q38012596-302470D3-6B53-428E-9BFA-33BE3157C7FB

Q38012596-5EDECA97-7035-4957-A377-8B85308570C5

Q38012596-7E22DA3A-BECB-4920-B632-0750E844ADED

Q38012596-A5D5DFC1-36E9-4E27-BA8F-66146E44A4EB

Q38012596-BC15BEFC-C550-41D7-8913-55E83002AAD3

Q38012596-DB92715D-08F2-4D4D-951E-19AC901BB2DB

Q38012596-E40599CC-0357-4CD4-9770-93FA4F4D8181

P577

Q38012596-63529224-CA9D-4ACE-B911-BC7C21330F0C

P698

Q38012596-845F2CFF-0533-4FE5-AD3B-57A64A2F83C5

P921

Q38012596-304715CC-1B78-48F9-B8BC-A4DE365E5066

P356

S10741-012-9323-1

P1433

Heart Failure Reviews

P1476

Soluble guanylate cyclase: a potential therapeutic target for heart failure.

@en

P2093

Academic Research Team in Heart Failure (ART-HF)

http://www.w3.org/2001/XMLSchema#string

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Catherine N Marti

http://www.w3.org/2001/XMLSchema#string

Hani N Sabbah

http://www.w3.org/2001/XMLSchema#string

John C Burnett

http://www.w3.org/2001/XMLSchema#string

John G F Cleland

http://www.w3.org/2001/XMLSchema#string

Lothar Roessig

http://www.w3.org/2001/XMLSchema#string

Michael Böhm

http://www.w3.org/2001/XMLSchema#string

Naoki Sato

http://www.w3.org/2001/XMLSchema#string

Phillip D Levy

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.

NO-independent regulatory site on soluble guanylate cyclase.

Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Soluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factor

Acute heart failure syndromes: current state and framework for future research.

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.

P2888

s10741-012-9323-1

P304

123-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-012-9323-1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Ponikowski

Gregg C. Fonarow

Mihai Gheorghiade

Johannes-Peter Stasch

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22622468

http://www.w3.org/2001/XMLSchema#string

P921